Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Step-up letrozole versus HMG for ovarian stimulation before intrauterine insemination in unexplained infertility
ACTRN12614000024640Phase 4Not yet recruiting
- Sponsor
- Alexandria University
- Start
- Jan 2014
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of letrozole, urofollitropin, menotropins and human chorionic gonadotropin in Unexplained infertility, sponsored by Alexandria University. Planned start Jan 2014; status: not yet recruiting.
02
Drugs
letrozoleurofollitropinmenotropinshuman chorionic gonadotropin
03
Conditions
Unexplained infertility
Beyond the preview
Go deeper on ACTRN12614000024640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000024640.